Volume 82, Issue 10, Pages (November 2012)

Slides:



Advertisements
Similar presentations
The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease  Ryo Matsuura, Kenjiro.
Advertisements

Volume 59, Issue 3, Pages (March 2001)
Volume 54, Issue 2, Pages (August 1998)
Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?
Current status of end-stage renal disease care in India and Pakistan
Oxidative stress and cystic fibrosis-related diabetes: A pilot study in children  Thierry Ntimbane, Preetha Krishnamoorthy, Céline Huot, Laurent Legault,
Recalcitrant pain in a patient with ADPKD
Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood
Volume 58, Issue 4, Pages (October 2000)
Parapelvic cysts leading to a diagnosis of Fabry disease
Volume 73, Issue 3, Pages (February 2008)
Current status of end-stage renal disease care in India and Pakistan
Volume 68, Issue 6, Pages (December 2005)
Rajiv Agarwal, John W. Kusek, Maria K. Pappas  Kidney International 
Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson 
Volume 78, Issue 8, Pages (October 2010)
Volume 79, Issue 11, Pages (June 2011)
Volume 66, Issue 4, Pages (October 2004)
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Volume 67, Issue 2, Pages (February 2005)
Volume 80, Issue 2, Pages (July 2011)
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children  Matthias Eyrich, Gernot.
Nat. Rev. Nephrol. doi: /nrneph
Volume 65, Issue 5, Pages (May 2004)
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 76, Issue 2, Pages (July 2009)
Volume 65, Issue 2, Pages (February 2004)
Volume 81, Issue 8, Pages (April 2012)
Comorbidity and confounding in end-stage renal disease
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load 
Volume 78, Issue 6, Pages (September 2010)
Gregory B. Vanden Heuvel  Kidney International 
Volume 76, Issue 3, Pages (August 2009)
Volume 70, Issue 2, Pages (July 2006)
Volume 59, Issue 5, Pages (May 2001)
Volume 74, Issue 9, Pages (November 2008)
Vasopressin regulation of renal sodium excretion
Volume 70, Issue 12, Pages (December 2006)
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 9, Pages (November 2008)
Progression of polycystic kidney disease in a kidney transplant
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Volume 74, Issue 8, Pages (October 2008)
Citrate therapy for polycystic kidney disease in rats
The initiation and progression of sickle cell nephropathy
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Unilateral renal cystic disease
Volume 81, Issue 9, Pages (May 2012)
Volume 86, Issue 4, Pages (October 2014)
Volume 74, Issue 9, Pages (November 2008)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 67, Issue 2, Pages (February 2005)
Volume 73, Issue 6, Pages (March 2008)
Volume 74, Issue 9, Pages (November 2008)
Volume 76, Issue 6, Pages (September 2009)
Volume 62, Issue 5, Pages (November 2002)
Volume 82, Issue 10, Pages (November 2012)
Volume 80, Issue 10, Pages (November 2011)
Volume 58, Issue 6, Pages (December 2000)
Volume 74, Issue 9, Pages (November 2008)
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla 
Volume 87, Issue 3, Pages (March 2015)
Volume 75, Issue 9, Pages (May 2009)
Vasopressin antagonists in polycystic kidney disease
Volume 72, Issue 11, Pages (December 2007)
Non-invasive assessment of kidney oxygenation: a role for BOLD MRI
Volume 67, Issue 4, Pages (April 2005)
Volume 68, Issue 5, Pages (November 2005)
The pretest probability of disease decreases with age in individuals who are born with 50% risk for autosomal dominant polycystic kidney disease (ADPKD)
Presentation transcript:

Volume 82, Issue 10, Pages 1121-1129 (November 2012) Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation  Thien Anh Ho, Nathalie Godefroid, Damien Gruzon, Jean-Philippe Haymann, Céline Maréchal, Xueqi Wang, Andreas Serra, Yves Pirson, Olivier Devuyst  Kidney International  Volume 82, Issue 10, Pages 1121-1129 (November 2012) DOI: 10.1038/ki.2012.225 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Relationship between plasma osmolality and vasopressin levels in autosomal dominant polycystic kidney disease (ADPKD) and controls (CTRLs). The correlation of individual parameters at baseline and after water deprivation shows that the positive relationship between plasma osmolality and plasma vasopressin (AVP), as observed in (a) controls, is blunted in (b) ADPKD patients. Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Correlation beween total renal volume and urinary concentrating ability in autosomal dominant polycystic kidney disease (ADPKD) patients. There is an inverse correlation between maximal urine concentration (Umax) and total renal volume measured by magnetic resonance imaging (MRI). The correlation is illustrated by MRI images of the kidneys of two representative patients: a 42-year-old man with few renal cysts shows a high urinary concentrating ability (959mOsm/kg), whereas a 40-year-old woman with large cystic kidneys shows a low urinary concentrating ability (464mOsm/kg). Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between plasma vasopressin and maximal urine osmolality in autosomal dominant polycystic kidney disease (ADPKD) patients and controls (CTRLs). The peripheral response to vasopressin was assessed by analyzing maximal urine concentration (Umax, after overnight water deprivation) as a function of plasma AVP. The dotted line represents the expected Umax in these conditions (800mOsm/kg). Black squares represent ADPKD patients, and open squares represent CTRL subjects. The two significant regression lines in CTRL (r2: 0.58; P=0.01) and ADPKD (r2: 0.46; P=0.03) are shown, with a displacement to the right indicating that a higher plasma AVP level is needed to achieve the same Umax in ADPKD vs. CTRL. For a similar range of plasma AVP, only 4/10 ADPKD patients vs. 9/10 CTRL subjects reached a Umax >800mOsm/kg (P=0.019). Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 Acute water loading in autosomal dominant polycystic kidney disease (ADPKD) patients and controls (CTRLs). A similar response to acute water loading—(a) increased urine output and (b) decreased urine osmolality (Uosm)—is observed in both groups. Both the timing and magnitude of changes are similar in ADPKD vs. controls. Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 5 Urine osmolality after overnight water deprivation in children with autosomal dominant polycystic kidney disease (ADPKD) and controls (CTRLs). Urine osmolality was obtained in 10 pairs of children with ADPKD vs. age- and gender-matched controls. The maximal urine osmolality (Umax) is significantly higher in CTRL than in ADPKD children (P=0.029). *P<0.05, CTRL vs. ADPKD. Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 6 Expression of polycystic kidney disease (PKD) genes in the hypothalamus. (a) Expression of Pkd1, Pkd2, and Avp genes (in situ hybridization) in the hypothalamic nuclei of the adult mouse. Data compiled from the Mouse Allen Brain Atlas (http://mouse.brain-map.org/). (b) Expression of PKD1, PKD2, and AVP in human brain. The expression profiles for AVP, PKD1, and PKD2 (microarray) in paraventricular nucleus (PVN) and supraoptic nucleus (SON) were obtained from Allen Brain Atlas (http://human.brain-map.org). The microarray data sets are presented as a matrix with brain structure, using a ‘heat map’ format in which the colors correspond to a normalized (z-score) expression level of each probe in coronal sections of magnetic resonance imaging (MRI) space around the hypothalamus. z is negative when the raw score is below the population mean and positive when above. The data shown in the Table are log2 expression values of each probe in each brain area. Expression data of AVP: donor=10021 and probes=1058921; expression data of PKD1: donor=10021 and probes=1053025; expression data of PKD2: donor=10021 and probes=1053021. PVN, paraventricular nucleus; SCN, suprachiasmatic nucleus; SON, supraoptic nucleus. Kidney International 2012 82, 1121-1129DOI: (10.1038/ki.2012.225) Copyright © 2012 International Society of Nephrology Terms and Conditions